Lv649
2102 积分 2023-04-07 加入
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial
20天前
已完结
Diffuse Large B-Cell Lymphoma
27天前
已完结
Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β
29天前
已完结
Harnessing CD8 T cell responses using PD-1–IL-2 combination therapy
1个月前
已完结
Safety and clinical activity of atezolizumab monotherapy in metastatic non-small-cell lung cancer: final results from a phase I study
1个月前
已完结
Safety and clinical activity of atezolizumab monotherapy in metastatic non-small-cell lung cancer: final results from a phase I study
1个月前
已完结
A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis
1个月前
已完结
Linking tumour angiogenesis and tumour immunity
1个月前
已完结
Development of bifunctional anti-PD-L1 antibody MMAE conjugate with cytotoxicity and immunostimulation
2个月前
已完结
Abstract 596: Development and assessment of a novel tumor microenvironment activable linker (TMALIN) ADC platform for solid tumor treatments
2个月前
已完结
皖公网安备34019202002308
